Luken Investment Analytics’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$553K Hold
478
– – 0.19% 45
2026
Q2
$573K Hold
478
– – 0.2% 45
2026
Q1
$440K Sell
478
-5
-1% -$5.07K 0.17% 46
2025
Q4
$519K Sell
483
-87
-15% -$83.2K 0.2% 37
2025
Q3
$435K Hold
570
– – 0.17% 41
2025
Q2
$444K Sell
570
-14
-2% -$10.9K 0.19% 39
2025
Q1
$482K Buy
584
+14
+2% +$11.6K 0.23% 34
2024
Q4
$440K Hold
570
– – 0.2% 34
2024
Q3
$505K Hold
570
– – 0.23% 31
2024
Q2
$516K Hold
570
– – 0.26% 34
2024
Q1
$443K Sell
570
-100
-15% -$71.2K 0.22% 32
2023
Q4
$391K Hold
670
– – 0.21% 34
2023
Q3
$360K Hold
670
– – 0.21% 35
2023
Q2
$314K Hold
670
– – 0.18% 35
2023
Q1
$230K Buy
670
+11
+2% +$3.71K 0.14% 38
2022
Q4
$241K Buy
+659
New +$234K 0.15% 35
2020
Q4
$73K Buy
+435
New +$64.9K 0.05% 46

Other funds holding LLY

Luken Investment Analytics's LLY Position: Q3 2026 in Review

Luken Investment Analytics held its Eli Lilly (LLY) position steady in Q3 2026 at 478 shares worth $553K. The position accounts for 0.19% of the portfolio, ranked #45.

Luken Investment Analytics first reported a position in LLY in Q4 2020 and has held it in 17 quarters since. The position peaked at $573K in Q2 2026. 2,846 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Luken Investment Analytics held 478 shares of Eli Lilly worth $553K as of Q3 2026.
  • Luken Investment Analytics left its Eli Lilly share count unchanged in Q3 2026.
  • Eli Lilly made up 0.19% of Luken Investment Analytics's portfolio in Q3 2026, its #45 holding.
  • Luken Investment Analytics first reported a position in Eli Lilly in Q4 2020 and has held it in 17 quarters since.
  • Luken Investment Analytics's Eli Lilly position peaked at $573K in Q2 2026.
  • 2,846 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Luken Investment Analytics's 13F filing for Q3 2026, filed 6 Nov 2026.